Jing Qi

Jing Qi

Auto-generated profile, based on publicly available information

Jing Qi

Nantong Univ, Res Ctr Clin Med, Affiliated Hosp, Med Sch, Nantong 226001, Peoples R China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2023 in Analytical Methods
Verified
Journal Article
Closed access
PDF file
JQJing Qi
Jing Qi
QQQianyi Qi
Qianyi Qi
ZZZhou Zhou
Zhou Zhou
YWYixuan Wu
Yixuan Wu
ACAiting Cai
Aiting Cai
FWFeng Wang
Feng Wang
The detection of epidermal growth factor receptor (EGFR) mutation L858R in circulating tumor DNA (ctDNA) is beneficial for the clinical diagnosis and personalized therapy of non-small cell lung cancer (NSCLC).

16 February 2018 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
XHXiaoying Hou
Xiaoying Hou
HDHongzhi Du
Hongzhi Du
RYRui Yang
Rui Yang
JQJing Qi
Jing Qi
YHYue Huang
Yue Huang
LSLi Sun
Li Sun
Chemotherapy is the preferred and most common treatment for cancer in clinical practice. An increasing number of researchers all over the world are focusing on natural medicines to find new antitumor drugs, and several reports have shown that Camellia nitidissima (C. nitidissima) Chi could reduce blood-lipid, decrease blood pressure, resist oxidation, prevent carcinogenesis and inhibit tumors. Therefore, the pharmacodynamics of the chemical constituents in C. nitidissima need to be investigated further. In the present study, 16 chemical constituents were isolated from the leaves of C. nitidissima, of which 6 compounds are reported to be found in this plant for the first time. Furthermore, all these phytochemicals were screened for antitumor activity on 4 common cancer cell lines, while compound 3, one oleanane-type triterpene, exhibited the most potential antitumor effects. Interestingly, to our knowledge, this was the first report that compound 3 inhibits cancer cells. Compound 3 inhibited EGFR-mutant lung cancer cell line, NCI-H1975 via apoptosis effect, with an IC50 of 13.37±2.05 µM at 48 h. Based on the data, compound 3 showed potential for antitumor drug development, suggesting the scientific basis for the antitumor activity of C. nitidissima.

1 November 2021 in Experimental Cell Research
Verified
Journal Article
Closed access
JQJing Qi
Jing Qi
YGYibing Guo
Yibing Guo
HHHongming Huang
Hongming Huang
JYJunzhong Yao
Junzhong Yao
LXLiancheng Xu
Liancheng Xu
XLXiaohong Li
Xiaohong Li

27 September 2024 in Materials Today Bio
Verified
Journal Article
Open access
JQJing Qi
Jing Qi
XCXuemin Cao
Xuemin Cao
HBHongyi Bao
Hongyi Bao
TZTuodi Zhang
Tuodi Zhang
YWYichen Wang
Yichen Wang
FWFeng Wang
Feng Wang
Fig. 1: Schematic illustration of the principle of the Dual targets driven SPEXPAR assisted MNAzyme (D-S-M) fluorescent biosensor for olfactory marker protein (OMP) detection. A. Workflow for detection of OMP in nasal swab. B. Isothermal Self-Primer EXPonential Amplification Reaction (SPEXPAR) amplification. C. The production of fluorescent signal by Multicomponent Nuclear Acid Enzyme (MNAzyme). The signal of OMP was amplified and changed into the detectable fluorescence signal based on the reactions of SPEXPAR and MNAzyme in the D-S-M fluorescence biosensor. The qualitative or quantitative analysis of OMP can be measured by the analysis of the fluorescence intensity.Image 1.